Diagnostics Biochem Canada Inc.

Manufacturing Innovative IVD
for the World Since 1973

At Diagnostics Biochem Canada Inc. (DBC), it has been our mission for over 45 years to develop and market unique immunoassay kits that make a difference in the field of diagnostics and in public health. As a manufacturer of high quality immunoassays to a global market, we are constantly looking for new technologies and applications that can lead to an improvement in the diagnosis of disease and ultimately impact the quality of life for people around the world.

DBC News

COVID-19 UPDATE

Diagnostics Biochem Canada receives Health Canada COVID-19 Medical Device Authorization for the sale of the DBC Anti-SARS-CoV-2 IgG ELISA Kit …

COVID-19 / Infectious Disease / News

Communiqué de Presse – Développement de tests ELISA pour la COVID-19

Aujourd’hui, Diagnostics Biochem Canada (DBC) annonce avoir développé des tests ELISA sérologiques pour la détermination des anticorps anti-COVID-19 dans le …

COVID-19 / Infectious Disease / News

Press Release – Developing ELISA test kits for COVID-19

Today, Diagnostics Biochem Canada (DBC) announced that they have developed ELISA test kits for the determination of anti-COVID-19 antibodies in …

News / Trade shows

Medlab Middle East 2020

DBC will be exhibiting at Medlab Middle East in Dubai, starting February 3rd until the 6th. Visit us at Z6 …

products

Please browse our line of ELISA and LIA kits. If you do not see a product available which you are interested in or would like additional product information, please contact us.